Your browser doesn't support javascript.
loading
What is a clinical practice guideline? A roadmap to their development. Special report from the Guidelines Task Force of the International League Against Epilepsy.
Jetté, Nathalie; Kirkpatrick, Martin; Lin, Katia; Fernando, Sanjaya M S; French, Jacqueline A; Jehi, Lara; Kumlien, Eva; Triki, Chahnez C; Wiebe, Samuel; Wilmshurst, Jo; Brigo, Francesco.
  • Jetté N; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Kirkpatrick M; Department of Child Health, University of Dundee, Dundee, UK.
  • Lin K; Neurology Division, Federal University of Santa Catarina, Florianópolis, Brazil.
  • Fernando SMS; Division of Pediatric Neurology, Colombo North Teaching Hospital and the National Epilepsy Center of Colombo, Colombo, Sri Lanka.
  • French JA; Department of Neurology, NYU Grossman School of Medicine, New York University, New York, New York, USA.
  • Jehi L; Cleveland Clinic Epilepsy Center, Cleveland, Ohio, USA.
  • Kumlien E; Department of Neuroscience, Uppsala University, Uppsala, Sweden.
  • Triki CC; Department of Child Neurology, Hedi Chaker Hospital, University of Sfax, Sfax, Tunisia.
  • Wiebe S; Department of Paediatric Neurology, Red Cross War Memorial Children's Hospital, Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
  • Wilmshurst J; Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
  • Brigo F; Department of Neurology, Hospital of Merano, Merano, Italy.
Epilepsia ; 63(8): 1920-1929, 2022 08.
Article en En | MEDLINE | ID: mdl-35722680
ABSTRACT
Clinical practice guidelines (CPGs) are statements that provide evidence-based recommendations aimed at optimizing patient care. However, many other documents are often published as "guidelines" when they are not; these documents, although also important in clinical practice, are usually not systematically produced following rigorous processes linking the evidence to the recommendations. Specifically, the International League Against Epilepsy (ILAE) guideline development toolkit aims to ensure that high-quality CPGs are developed to fill knowledge gaps and optimize the management of epilepsy. In addition to adhering to key methodological processes, guideline developers need to consider that effective CPGs should lead to improvements in clinical processes of care and health care outcomes. This requires monitoring the effectiveness of epilepsy-related CPGs and interventions to remove the barriers to epilepsy CPG implementation. This article provides an overview of what distinguishes quality CPGs from other documents and discusses their benefits and limitations. We summarize the recently revised ILAE CPG development process and elaborate on the barriers and facilitators to guideline dissemination, implementation, and adaptation.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Comités Consultivos / Epilepsia Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Comités Consultivos / Epilepsia Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article